Monday, 23 July 2018

Cell Isolation Market 2018 Share, Trend, Segmentation and Forecast to 2023

Market Scenario
The cell isolation market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the cell isolation market is expected to grow at a CAGR ~17.8 % during the forecast period of 2018–2023.
Cell isolation is the process of separating individual living cells from a cluster of tissue or cell suspension.  It may be used for volume reduction of blood components, recovery of mononucleated cells from cord blood, the concentration of bone marrow, and other cell isolation applications.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6193
The market growth is mainly attributed to the increasing prevalence of cancer and infectious diseases and rising government funding for cell-based research. For instance, in 2015, the National Institutes of Health invested around 1,429 million USD for stem cells research. Moreover, technological advancements, growing research on personalized medicine and increasing demand for biopharmaceuticals is likely to contribute to the market growth during the forecast period. Despite the drivers, the high cost of cell isolation systems and complex cell behavior characteristics restrains the growth of the market.
Segmentation
The cell isolation market is segmented on the basis of product, cell type, technique, application, and end-user.
On the basis of the product, the market is classified as consumables and instruments. The consumables are further classified as reagents, kits, media, and sera, beads, disposables. The instruments are segmented into centrifuges, flow cytometers, magnetic-activated cell separation, and filtration system. The magnetic-activated cell separator system is further classified into manual magnetic-activated cell separator systems and automated magnetic-activated cell separator systems.
On the basis of cell type, the market is segmented into human cells and animal cells. The human cells are further segmented into differentiated cells and stem cells.
The cell isolation market on the basis of the technique is segmented as centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation.
On the basis of the application, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics.
On the basis of the end-user, the market is segmented as research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, biotechnology and biopharmaceutical companies.
Geographically, cell isolation market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas cell isolation market is further segmented into North America, and South America. North America is further classified as the US and Canada.
The European cell isolation market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.
The Asia-Pacific cell isolation market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia-Pacific.
The Middle Eastern and African cell isolation market is segmented into the Middle East and Africa.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/6193

Regional Market Summary
The American region is expected to dominate the cell isolation market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, increasing government funding in research, and technological advancements. According to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer had been diagnosed in the US Furthermore, the increasing cancer care expenditure in the United States is likely to drive the market growth. For instance, in 2017, the US Department of Health and Human Services estimated 147.3 billion USD national expenditures for cancer care.
Europe is anticipated to hold the second position in the cell isolation market. It is expected that the government support towards research & development expenditure and rising prevalence chronic diseases such as cancer is likely to drive the European cell isolation market.  According to the Cancer Research UK, in 2012, 14.1 million cases of cancer were diagnosed all over the world, and 8.2 million died due to cancer. It also projected that the number of cancer patients is expected to reach 23.6 million in 2030.
The Asia-Pacific cell isolation market consists of countries namely China, Japan, Republic of Korea, India, and Australia. The market growth is mainly driven by rapidly expanding biopharmaceutical industries in the region and rising government funding in life sciences sector. Moreover, countries like India and China have established research institutes promoting cell-based research which contributes to the market growth.
The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.
Company Profiles    
  • Beckman Coulter (Subsidiary of Danaher Corporation)
  • Becton, Dickinson, and Company
  • GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec
  • Pluriselect Life Science
  • Stemcell Technologies Inc.
  • Terumo Bct (A Subsidiary of Terumo Corporation)
  • Bio-Rad Laboratories, Inc.
Table of Contents
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Treatment Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6193  

        
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Hyperglycemia Treatment Market- Global Industry Size, Share, Trends, Analysis and Forecast 2018 – 2023


Market Scenario
Hyperglycemia is an excess of glucose in the bloodstream, and is often associated with diabetes mellitus. It occurs when the body does not have enough insulin to control the sugar level or unable to produce the insulin. Furthermore, hyperglycemia if remains untreated may cause serious complications such as nerve damage or neuropathy, kidney damage, kidney failure, cardiovascular disease, eye disease, and skin problems such as bacterial and fungal infections. The major signs of hyperglycemia are polydipsia (a great thirst), polyuria (a need to urinate often), and a dry mouth.
Increasing prevalence of diabetes, and growing investment in biotechnology and pharmaceutical industries, and rising need for the better treatment methods drive the growth of the market.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4565

According to the WHO, the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. Where as in 2015, 1.6 million deaths were caused due to diabetes. Another, 2.2 million deaths were attributed to high blood glucose level in 2012.
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies across the globe. This is higher than the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.
Moreover, increasing awareness about diabetes care and management, and advancing technology in medical devices are adding fuel to the growth of the market. Furthermore, increasing prevalence of obesity and consumption of unhealthy diet also drive the market growth. 
However, availability of expensive treatment and poor reimbursement policy are some of the factors, which may slow the market growth during the forecast period.
The global hyperglycemia treatment market is expected to grow at a CAGR of  9.8 % during the forecast period 2017-2023.

Intended Audience
  • Pharmaceutical Companies
  • Medical Devices Companies
  • Research and Development (R&D) Companies
  • Government Research Institute
  • Academic Institutes and Universities
Segmentations
The global hyperglycemia treatment market is segmented on the basis of treatment, mode of administration, and end user.
On the basis of treatment, it is segmented into fluid replacement, electrolyte replacement, insulin therapy, and drugs. The drugs segment is further segmented into sulfonylureas, biguanides, thiazolidinediones, and others.
On the basis of mode of administration, it is segmented into topical, oral, and others.
On the basis of end user, the market is segmented into hospitals & clinics, retail pharmacy, and others
Regional Analysis
The Americas dominates the global hyperglycemia treatment market owing to well-developed technology, increasing patient with diabetes, increasing prevalence of neurological disorders, increasing patient population of kidney failure caused by severe hyperglycemia, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global hyperglycemia treatment market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.
Asia Pacific is the fastest growing hyperglycemia treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as  the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of the hyperglycemia treatment in the region.
On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.
Key Players
Some of key the players in the market are Novo Nordisk A/S, Merck & Company Inc., Medtronic, Johnson & Johnson Services, Inc. , Teva Pharmaceuticals Ltd., Eli Lilly and Company, Sanofi S.A., Home Diagnostics, Bayer AG, Bristol-Myers Squibb., and Abbott.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4565   

MAJOR TOC
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
… Continued!

Send An Enquiry @  https://www.marketresearchfuture.com/enquiry/4565   

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com


Posted by at No comments:

Thursday, 19 July 2018

Cell Isolation Market: Global Major Key Players Research – Forecast to 2023

Market Scenario
The cell isolation market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the cell isolation market is expected to grow at a CAGR ~17.8 % during the forecast period of 2018–2023.
Cell isolation is the process of separating individual living cells from a cluster of tissue or cell suspension.  It may be used for volume reduction of blood components, recovery of mononucleated cells from cord blood, the concentration of bone marrow, and other cell isolation applications.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/6193
The market growth is mainly attributed to the increasing prevalence of cancer and infectious diseases and rising government funding for cell-based research. For instance, in 2015, the National Institutes of Health invested around 1,429 million USD for stem cells research. Moreover, technological advancements, growing research on personalized medicine and increasing demand for biopharmaceuticals is likely to contribute to the market growth during the forecast period. Despite the drivers, the high cost of cell isolation systems and complex cell behavior characteristics restrains the growth of the market.
Segmentation
The cell isolation market is segmented on the basis of product, cell type, technique, application, and end-user.
On the basis of the product, the market is classified as consumables and instruments. The consumables are further classified as reagents, kits, media, and sera, beads, disposables. The instruments are segmented into centrifuges, flow cytometers, magnetic-activated cell separation, and filtration system. The magnetic-activated cell separator system is further classified into manual magnetic-activated cell separator systems and automated magnetic-activated cell separator systems.
On the basis of cell type, the market is segmented into human cells and animal cells. The human cells are further segmented into differentiated cells and stem cells.
The cell isolation market on the basis of the technique is segmented as centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation.
On the basis of the application, the market is segmented into biomolecule isolation, cancer research, stem cell research, tissue regeneration, in vitro diagnostics, and therapeutics.
On the basis of the end-user, the market is segmented as research laboratories and institutes, hospitals and diagnostic laboratories, cell banks, biotechnology and biopharmaceutical companies.
Geographically, cell isolation market has been segmented into America, Europe, Asia-Pacific, and the Middle East & Africa. The Americas cell isolation market is further segmented into North America, and South America. North America is further classified as the US and Canada.
The European cell isolation market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.
The Asia-Pacific cell isolation market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia-Pacific.
The Middle Eastern and African cell isolation market is segmented into the Middle East and Africa.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/6193

Regional Market Summary
The American region is expected to dominate the cell isolation market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, increasing government funding in research, and technological advancements. According to the National Cancer Institute, in 2016, around 1,685,210 new cases of cancer had been diagnosed in the US Furthermore, the increasing cancer care expenditure in the United States is likely to drive the market growth. For instance, in 2017, the US Department of Health and Human Services estimated 147.3 billion USD national expenditures for cancer care.
Europe is anticipated to hold the second position in the cell isolation market. It is expected that the government support towards research & development expenditure and rising prevalence chronic diseases such as cancer is likely to drive the European cell isolation market.  According to the Cancer Research UK, in 2012, 14.1 million cases of cancer were diagnosed all over the world, and 8.2 million died due to cancer. It also projected that the number of cancer patients is expected to reach 23.6 million in 2030.
The Asia-Pacific cell isolation market consists of countries namely China, Japan, Republic of Korea, India, and Australia. The market growth is mainly driven by rapidly expanding biopharmaceutical industries in the region and rising government funding in life sciences sector. Moreover, countries like India and China have established research institutes promoting cell-based research which contributes to the market growth.
The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.
Company Profiles    
  • Beckman Coulter (Subsidiary of Danaher Corporation)
  • Becton, Dickinson, and Company
  • GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec
  • Pluriselect Life Science
  • Stemcell Technologies Inc.
  • Terumo Bct (A Subsidiary of Terumo Corporation)
  • Bio-Rad Laboratories, Inc.
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/6193  

        
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Wednesday, 18 July 2018

Corneal Transplant Market Size, Share, Revenue Analysis and Forecasts to 2023

Market Synopsis of the Global Corneal Transplant Market
Corneal transplant is a procedure to replace the damaged or diseased cornea which may be due to eye injury or eye disease. Two major types of corneal transplants are penetrating keratoplasty (full thickness cornea transplant) and endothelial keratoplasty (back layer cornea transplant). Need for corneal transplant may rise if the diseased cornea leads to blurred vision.  According to the World Health Organization (WHO), 285 million people are estimated to be visually impaired worldwide.
The market for corneal transplant shows exponential growth due to high prevalence of corneal eye disease and rising number of corneal transplants in developed countries. High cost of corneal transplants may restrain the market growth. For instance, the cost of corneal transplant is higher in U.S. than other countries in the Asia Pacific.
The global corneal transplant market is expected to grow at a CAGR of 8.5% during the forecast period 2017 to 2023.
Intended Audience
  • Eye Hospitals
  • Eye Surgery Centers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors
Key Players in the Global Corneal Transplant Market  
Some of the key players in this market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Segments                                                                                                                                            
The global corneal transplant market is segmented on the basis of type, indication, and end user.
On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.
On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.
On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

Table Of Content
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry


        
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

The Kidney Function Test Market Segments, Top Key Players Strategies and Forecasts Till 2023

Market Scenario
The kidney function test market is expected to witness growth owing to the rising prevalence of chronic kidney diseases. According to the Centers for Disease Control and Prevention (2017), 30 million people in the U.S. suffer from Chronic Kidney Disease (CKD). Other key factors such as an increase in alcohol consumption, change to sedentary lifestyle, growing prevalence of diabetes, rising obesity, and increasing prevalence of cardiovascular diseases are contributing towards the growth of the market. Diabetes is associated with kidney disorders because diabetes damage the blood vessels of kidneys which leads to improper functioning of kidneys. Such conditions contribute to risk for kidney disorders. According to the Centers for Disease Control and Prevention 2017, 44% of the diabetic patients suffered from End-Stage Renal Disease (ESRD) in the U.S. The prevalence of diabetes increases the potential patients for kidney function test, providing favorable backgrounds for the market to grow. Also, other factors such as growing geriatric population and technological advancements drive the growth of the market.
However, factors such as high cost of diagnostic procedures, infections, and huge initial investments are expected to restrict the market growth during the forecast period.
Segmentation
The global kidney function test market is segmented on the basis of tests, product, and end-user. The kidney function test market, by tests, is categorized into blood tests, imaging tests, urine tests balloons, and kidney biopsy. The blood tests category includes serum creatinine, Glomerular Filtration Rate (GFR), and Blood Urea Nitrogen (BUN). The imaging tests segment includes ultrasound and CT scan. The urine tests category includes urinalysis, urine protein, microalbuminuria, and creatinine clearance. The product segment is segmented into dipsticks, disposables, and reagents. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic laboratories, ambulatory surgical centers, academic research laboratories, and others.     
Key players
Some of the key players in the global kidney function test market are Urit Medical, Sysmex Corporation, Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY, Inc., Acon Laboratories, Abbott, Cook Medical, 77 Elektronika, Medical Care (Germany), Baxter (U.S.), Boston Scientific (U.S.), and others.
Regional Market Summary
The kidney function test market is dominated by North America owing to the rising prevalence of chronic kidney diseases. According to the Centers for Disease Control and Prevention in 2017, 15% of the Americans are estimated to have chronic kidney diseases. The presence of major market players such as Baxter, Cook Medical, C. R. Bard, Inc., and others within the region, influences the market growth. Other factors such as increasing healthcare expenditure and increasing obesity within the population drive the market growth in this region.
It is estimated that Europe stood second in the global kidney function test market owing to the increasing prevalence of chronic kidney diseases. According to the European Renal Association and the European Dialysis and Transplant Association (ERA-EDTA), 70 million people in Europe suffer from some or the other type of kidney disease. Thus, the increasing prevalence of Chronic Kidney Diseases (CKD) in this region influences the growth of the market in this region.
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
...Continued

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Electronic Pill Market Share Analysis, Strategies, Revenue and Forecasts to 2023

Market Scenario
The global electronic pill market is expected to reach an approximate CAGR of 15% during the forecast period. The electronic pill is an ingestible capsule that is embedded with sensors and camera. After ingesting the pill, the pill captures several images per second of the gastrointestinal tract which is received by the connected recording device. It is a monitoring system used to monitor temperature, pH, conductivity and dissolved oxygen. Electronic Pills are used for diagnostics of various gastrointestinal tract diseases like colon cancer, colon polyps, gastrointestinal bleeding and other infectious diseases. The increase in preference of non-invasive methods for diagnostics is driving the growth of the market. Moreover, the rising geriatric population, increasing prevalence of gastrointestinal diseases like colorectal cancer, changing lifestyle, increasing unhealthy eating habits, controlled drug delivery and better way of endoscopy procedures are major factors influencing the growth of the market.
According to the American Cancer Society, Inc. in 2017, 27,150 men and 23,110 women had colorectal cancer in the US. Thus, such a high incidence rate of colorectal cancer provides favorable backgrounds for the market growth. Also, growing demand for rapid and precise diagnostics, adoption of advanced technology are the key factors for the market to grow.
However, factors such as bowel obstruction, lack of awareness, capsule retention and high costs are expected to restrict the market growth during the forecast period.
Segmentation
The global electronic pill market is segmented on the basis of Application, Target area, Parts and end user. The electronic pill market, by application, is sub-segmented into Capsule Endoscopy, Drug Delivery, and Patient Monitoring. Target area category includes Oesophagus, Stomach, Small Intestine, and large intestine.
By parts, the market is categorized into biocompatible capsule encasing microsensors, Control chip, Radio transmitter and Power source. On the basis of end-user, the market is segmented into Hospitals, Diagnostic centers, Clinical Research Organizations and Medical Centers.
On the basis of region, the global Electronic Pill market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the U.K., Spain, and the rest of Western Europe. The Asia Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.
Global Electronic Pill Market, by Key Players
  • CapsoVision, Inc. (US),
  • Given Imaging Ltd. (Israel),
  • Medimetrics (Mexico),
  • Bio-Images Drug Delivery BDD LTD (UK),
  • Proteus Digital Health (US),
  • Olympus Corporation,
  • Medtronic,
  • Medisafe,
  • JINSHAN Science & Technology,
  • INTROMEDIC
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)